ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2563

Factors Associated with Major Cardiovascular Events in Patients with Primary Systemic Necrotizing Vasculitides: Results of a Longitudinal Long-Term Follow-up Study

Benjamin Terrier1, Christian Pagnoux2, Gilles Chironi3, Alain Simon3, Luc Mouthon4, Loic Guillevin5 and French Vasculitis Study Group (FVSG)6, 1Internal Medicine, Cochin University Hospital, Paris, France, 2Rheumatology, Mount Sinai Hospital, Toronto, Canada, Toronto, ON, Canada, 3HEGP, Paris, France, 4Internal Medicine, Hopital Cochin, Paris, France, 5Internal Medicine, Division of Internal Medicine, Hôpital Cochin, University Paris Descartes, Paris, France, 6Paris

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Cardiovascular disease, intima medial thickness, obesity and vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Vasculitis: Clinical Aspects

Session Type: Abstract Submissions (ACR)

Background/Purpose: Primary systemic necrotizing vasculitides (SNV) were shown to be associated with more frequent subclinical atherosclerosis, independently of cardiovascular (CV) risk factors and C-reactive protein (CRP) level, suggesting that SNV might be associated with a higher risk of major CV events (MCVE).

Objective : To identify factors predictive of MCVE in SNV patients.

Methods: Consecutive patients in SNV remission were assessed for CV risk factors, body mass index (BMI), CRP levels and subclinical atherosclerosis [ultrasound detection of plaque in peripheral vessels and measurement of carotid intima–media thickness (IMT)], and prospectively followed in the same center. High-risk status, defined according to the National Cholesterol Education Program Adult Treatment Panel III (NCEP/ATP III), was a known history of CV disease, diabetes or 10-yr Framingham Risk Score ≥20%. MCVE, defined as myocardial infarction, stroke, arterial revascularization, hospitalization for unstable angina and/or death from CV causes, were recorded. Kaplan–Meier MCVE-free survival curves were plotted and compared with the log-rank test.

Results:

Thirty-seven patients (24 males, age 54 ± 15 yr) were followed for 7.0 ± 2.6 yr. SNV diagnoses were: granulomatosis with polyangiitis, 19; eosinophilic granulomatosis with polyangiitis, 8; microscopic polyangiitis, 7; and polyarteritis nodosa, 3. Seven (18.9%) patients suffered MCVE, including myocardial infarction or hospitalization for unstable angina (n=4), arterial revascularization (n=2), and CV cause of death (n=1). The respective 5- and 10-yr MCVE rates were 10.8% and 25.7%.

Univariate analysis selected NCEP/ATP III-defined high-risk status [hazard ratio (HR) 5.02 (95% CI 1.17–27.4), P=0.03], BMI >30 kg/m2 [HR 4.84 (95% CI 1.46–116), P=0.02] and plaque detection in the abdominal aorta (P=0.01) as being significantly associated with MCVE. In contrast, SNV characteristics, corticosteroid maintenance therapy, CRP >5 mg/L, and plaque detection in the carotid and femoral arteries were not associated with MCVE. Plaque in the aorta was significantly (χ2 test) associated with high-risk status (P<0.001), while BMI and high-risk status were independent variables (P=0.64). Thus, a BMI >30 kg/m2 and/or a high-risk status were strongly associated with MCVE (P=0.003).

Finally, although IMT was not associated with MCVE, it distinguished between patients with early or late MCVE: 30% of patients with IMT >0.60 mm (vs none of those with IMT ≤0.60 mm) experienced MCVE within the first 3 yr of follow-up, while 23% of patients with IMT ≤0.60 mm (vs none of those with IMT >0.60 mm) experienced a 1st MCVE after 7–10 yr of follow-up. IMT was correlated with the time to MCVE (r2=0.78, P=0.008).

Conclusion: These results suggest that factors associated with a higher MCVE risk in SNV patients are NCEP/ATP III-defined high-risk status and BMI >30 kg/m2. Carotid IMT measurement in SNV patients could help identify those at risk of early MCVE.


Disclosure:

B. Terrier,
None;

C. Pagnoux,
None;

G. Chironi,
None;

A. Simon,
None;

L. Mouthon,
None;

L. Guillevin,
None;

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/factors-associated-with-major-cardiovascular-events-in-patients-with-primary-systemic-necrotizing-vasculitides-results-of-a-longitudinal-long-term-follow-up-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology